Standout Papers

Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pan... 2010 2026 2015 2020 667
  1. Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303) (2010)
    Hedy L. Kindler, Donna Niedzwiecki et al. Journal of Clinical Oncology

Immediate Impact

2 by Nobel laureates 9 from Science/Nature 81 standout
Sub-graph 1 of 21

Citing Papers

Targeting the tumour vasculature: from vessel destruction to promotion
2024 Standout
Pancreatic cancer: Advances and challenges
2023 Standout
15 intermediate papers

Works of Susan Sutherland being referenced

Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)
2010 Standout

Author Peers

Author Last Decade Papers Cites
Susan Sutherland 707 356 143 287 15 1.1k
B. Mirtsching 1124 452 125 284 24 1.3k
Timothy F. Wozniak 720 222 84 400 16 949
Martha Donoghue 654 374 157 265 26 1.1k
Yifah Yaron 608 376 145 149 17 1.3k
V. Weinberg 615 443 247 463 18 1.3k
Lisa Rodríguez 573 297 154 234 19 984
Charlotte Dion‐Blanc 672 352 66 128 23 1.1k
Jesse W. Keller 847 367 44 354 14 1.0k
Shannon McDonough 963 257 242 293 35 1.2k
Yukinori Murata 827 375 93 170 22 1.3k

All Works

Loading papers...

Rankless by CCL
2026